Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficiency Study of Low-dose IL-2 Treatment in Systemic Lupus Erythematosus

NCT02084238 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT02084238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficiency Study of Low-dose IL-2 Treatment in Systemic Lupus Erythematosus
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
October 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus